Zihan Yi

448 total citations
17 papers, 297 citations indexed

About

Zihan Yi is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Zihan Yi has authored 17 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Zihan Yi's work include Cancer, Hypoxia, and Metabolism (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Autophagy in Disease and Therapy (3 papers). Zihan Yi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Autophagy in Disease and Therapy (3 papers). Zihan Yi collaborates with scholars based in China. Zihan Yi's co-authors include Yingmin Kuang, Zhe Yang, Yuechun Zhu, Qiaoqiao Han, Lu Jiang, Lijuan Yang, Huixin Yang, Qiao Zhang, Qiao Zhang and Qiao Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Cancer Research and Cell Death and Differentiation.

In The Last Decade

Zihan Yi

14 papers receiving 296 citations

Peers

Countries citing papers authored by Zihan Yi

Since Specialization

Citations

This map shows the geographic impact of Zihan Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zihan Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zihan Yi more than expected).

Fields of papers citing papers by Zihan Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zihan Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zihan Yi. The network helps show where Zihan Yi may publish in the future.

Co-authorship network of co-authors of Zihan Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Zihan Yi. A scholar is included among the top collaborators of Zihan Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zihan Yi. Zihan Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	China's New Energy Electric Vehicle Industry: Multifaceted Analysis and Future Outlook 2025 ·Zihan Yi	0
2	NDUFS3 promotes proliferation via glucose metabolism reprogramming inducing AMPK phosphorylating PRPS1 to increase the purine nucleotide synthesis in melanoma 2025 ·Cell Death and Differentiation ·(unknown), Yun Fang, Lu Jiang, Zihan Yi, (unknown), Lijuan Yang, (unknown), Xiaoyu Li, (unknown), Qiao Zhang, Buqing Sai, Yingmin Kuang, Yuechun Zhu	1
3	A BRAF-activated noncoding RNA attenuates clear cell renal cell carcinoma via repression of glucose-6-phosphate dehydrogenase 2025 ·Journal of Biological Chemistry ·Wenjing Liu, (unknown), (unknown), Xiangjie Liu, Asif Shahzad, Kun Cui, (unknown), (unknown), (unknown), Zihan Yi, Buqing Sai, (unknown), (unknown), (unknown), Qiao Zhang, (unknown)	0
4	mTOR and autophagy in acute lung injury pathogenesis and therapeutic potential 2025 ·Journal of Thoracic Disease ·Zihan Yi, Jiahao Liu, (unknown), Yue Hu	0
5	Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics 2024 ·Clinical Cancer Research ·Xiaoqi Peng, Hongbo Zhao, (unknown), Fei Hou, Zihan Yi, (unknown), (unknown), Fukun Chen, Juan Lv, (unknown), (unknown), (unknown), (unknown), (unknown)	1
6	NRF2-directed PRPS1 upregulation to promote the progression and metastasis of melanoma 2022 ·Frontiers in Immunology ·(unknown), Feng Yu, (unknown), (unknown), (unknown), Lijuan Yang, Zihan Yi, Buqing Sai, Zhe Yang, Qiao Zhang, Yingmin Kuang, Yuechun Zhu	6
7	Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer 2021 ·Journal of Cancer ·Shujie Wang, Wenjing Liu, (unknown), Lifeng Wang, (unknown), Qiong Shi, Zihan Yi, Wen‐Jie Wang, Lili Liu, Lijuan Yang, Yingmin Kuang, Yuechun Zhu, Qiao Zhang, Zhe Yang	6
8	G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression 2021 ·International Journal of Medical Sciences ·Qiao Zhang, (unknown), Shujie Wang, (unknown), Qiaoqiao Han, Wenjing Liu, (unknown), Zihan Yi, (unknown), (unknown), Buqing Sai, Lijuan Yang, Qiong Shi, Yingmin Kuang, Zhe Yang, Yuechun Zhu	10
9	Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin‐related modifier 1 modification of glucose 6‐phosphate dehydrogenase 2021 ·Cancer Science ·(unknown), Zhe Yang, (unknown), (unknown), (unknown), Lijuan Yang, Zihan Yi, Jing Cheng, Qiao Zhang, Yingmin Kuang, Yuechun Zhu	17
10	LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis 2020 ·BMC Cancer ·(unknown), (unknown), (unknown), (unknown), Jing Chen, Yun Fang, Zihan Yi, (unknown), Zhe Yang, Yingmin Kuang, Yuechun Zhu	11
11	NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC 2020 ·Cancer Cell International ·Qiao Zhang, Zhe Yang, (unknown), (unknown), Qiaoqiao Han, Zihan Yi, (unknown), (unknown), Yingmin Kuang, Yuechun Zhu	16
12	Association between diabetes mellitus and lung cancer: Meta‐analysis 2020 ·European Journal of Clinical Investigation ·Zihan Yi, (unknown), (unknown), (unknown), Yun Fang, Jing Chen, Zhe Yang, Qiao Zhang, Yingmin Kuang, Yuechun Zhu	28
13	G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway 2020 ·International Journal of Oncology ·Qiao Zhang, Qiaoqiao Han, Zhe Yang, (unknown), (unknown), (unknown), Zihan Yi, (unknown), Yingmin Kuang, Yuechun Zhu	29
14	Glutathione peroxidase 3 (GPX3) suppresses the growth of melanoma cells through reactive oxygen species (ROS)‐dependent stabilization of hypoxia‐inducible factor 1‐α and 2‐α 2019 ·Journal of Cellular Biochemistry ·Zihan Yi, Lu Jiang, (unknown), Meiling Zhou, (unknown), (unknown), Huixin Yang, Lijuan Yang, Qiao Zhang, Yingmin Kuang, (unknown), (unknown)	45
15	LncRNA GAS5 regulates redox balance and dysregulates the cell cycle and apoptosis in malignant melanoma cells 2018 ·Journal of Cancer Research and Clinical Oncology ·Long Chen, Huixin Yang, Zihan Yi, Lu Jiang, Yuqian Li, Qiaoqiao Han, (unknown), Qiao Zhang, Zhe Yang, Yingmin Kuang, (unknown)	54
16	Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma 2017 ·Journal of Cancer ·Qiao Zhang, (unknown), Zhe Yang, Qiaoqiao Han, (unknown), (unknown), Yanling Wang, Zihan Yi, Yingmin Kuang, Yuechun Zhu	35
17	G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3 2017 ·Oncotarget ·Qiao Zhang, Zhe Yang, Qiaoqiao Han, (unknown), Yanling Wang, (unknown), Zihan Yi, Lijuan Yang, Lu Jiang, Xin Song, Yingmin Kuang, Yuechun Zhu	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact